Lataa...
Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention
Abciximab is a widely studied glycoprotein IIb/IIIa inhibitor, specifically in the setting of patients undergoing percutaneous coronary intervention (PCI). The populations studied have included patients with non-ST-segment acute coronary syndromes, ST-segment elevation myocardial infarction, and ele...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2835553/ https://ncbi.nlm.nih.gov/pubmed/20234778 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|